• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Lannett Rises After Announcing Adderall Distribution Agreement
STOCKS

Acadia Pharma Jumps on Positive Data From Depression Treatment Candidate

  • By Tony Owusu
  • Sep 23, 2019 11:17 AM EDT
Newell Brands, Emerson Electric, CPI: Cramer's 'Mad Money' Game Plan
JIM CRAMER

Too Much Optimism: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Sep 12, 2019 8:47 PM EDT
Aquinox Pharma Shares Plunge 85% After Failed Test Results
INVESTING

Acadia Pharmaceuticals Surges on Positive Trial Results for Psychosis Treatment

  • By M. Corey Goldman
  • Sep 9, 2019 11:31 AM EDT
Amgen Takes $2.7 Billion Stake in BeiGene to Expand Access to China
STOCKS

Acadia Falls Sharply in After-Hours Trading After Schizophrenia Drug Fails Study

  • By Tom Bemis
  • Jul 22, 2019 5:56 PM EDT
Warren Buffett's Berkshire Hathaway Posts Record Third-Quarter Profit
JIM CRAMER

Berkshire Hathaway, Oneok, FNB Corp.: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Nov 28, 2018 8:45 PM EST
How Much Tighter?: Cramer's 'Mad Money' Recap (Wednesday 10/3/18)
JIM CRAMER

Fed Fuels This Rally: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Nov 28, 2018 8:38 PM EST
Dropbox's Selloff After a Solid Earnings Report Is a Cautionary Tale
JIM CRAMER

Dropbox, XPO Logistics, Ford Motor: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Oct 24, 2018 11:04 PM EDT
Retail Stocks Are Being Mysteriously Pounded on Monday
JIM CRAMER

Don't Forget the Consumer: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Oct 24, 2018 11:04 PM EDT
Lennar, LG Homes, GrubHub, Sprint: 'Mad Money' Lightning Round
JIM CRAMER

Lennar, LG Homes, GrubHub, Sprint: 'Mad Money' Lightning Round

  • By Scott Rutt
  • Apr 20, 2018 6:55 AM EDT
Tech Alone Can't Save the Rally: Cramer's 'Mad Money' Recap (Tuesday 6/5/18)
JIM CRAMER

A Flash Flood of Selling: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Apr 20, 2018 6:25 AM EDT
Samsung, Intel, Alibaba - 5 Things You Must Know Before the Market Opens Tuesday
JIM CRAMER

What's Holding Up This Market?: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Dec 12, 2017 6:16 AM EST
7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods
MERGERS AND ACQUISITIONS

7 Potential New Targets for Activist Investor That Made a Killing on Whole Foods

  • By Ronald Orol
  • Jul 21, 2017 1:15 PM EDT
Amazon's Whole Foods Deal Is a Major Win for Activist Jana Partners
INVESTING

Jana Partners Liquidates Whole Foods Stake After Engineering Industry-Transforming Sale To Amazon

  • By Ronald Orol
  • Jul 19, 2017 4:46 PM EDT
Trader's Daily Notebook: Worried About Volume? Just Let It Go
INVESTING

Why I Hate the FAANGs (but Like Banks and Biotech) for 2017's Second Half

  • By Bret Jensen
  • Jul 10, 2017 4:02 PM EDT
Jana Nominates Former Kellogg Executive for Whole Foods Board
MERGERS AND ACQUISITIONS

The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next

  • By Ronald Orol
  • Jun 19, 2017 9:47 PM EDT
The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views
INVESTING

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

  • By Doug Kass
  • May 1, 2017 1:00 AM EDT
The Good, the Bad and the Ugly; Explaining the Inexplicable: Doug Kass' Views
INVESTING

Takeaways and Observations; What's Driving My Approach: Doug Kass' Views

  • By Doug Kass
  • May 1, 2017 1:00 AM EDT
IBM, Apple, Amazon: Doug Kass' Views
INVESTING

Twitter, Netflix, MetLife: Doug Kass' Views

  • By Doug Kass
  • Mar 27, 2017 1:00 AM EDT
Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
STOCKS

Sage Therapeutics leads biotech movers on erroneous takeout rumor

  • By Alicia McElhaney
  • Feb 17, 2017 9:42 AM EST
Biotech Stock Mailbag: Trump, Aurinia, Immunomedics, Cellceutix
STOCKS

Biotech Stock Mailbag: Bulls love a distracted Trump, Protalix, Acadia, Sarepta

  • By Adam Feuerstein
  • Feb 17, 2017 7:44 AM EST
Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet
STOCKS

Acadia Pops on Takeout Rumors, But Don't Buy on M&A Just Yet

  • By Alicia McElhaney
  • Feb 3, 2017 1:29 PM EST
Twitter, Coty, Micron Technology: Doug Kass' Views
INVESTING

Allergan, apple, facebook: doug kass' views

  • By Doug Kass
  • Jan 23, 2017 1:00 AM EST
Market Circles Back; Nat Gas a Big Winner: Jim Cramer's View
INVESTING

Allergan, citigroup, apple: doug kass' views

  • By Doug Kass
  • Jan 16, 2017 1:00 AM EST
17 Thoughts on Biotech Stocks to Kick Off 2017
STOCKS

17 thoughts on biotech stocks to kick off 2017

  • By Adam Feuerstein
  • Jan 3, 2017 6:35 AM EST
Starbucks, Allergan, Amazon: Doug Kass' Views
MERGERS AND ACQUISITIONS

Starbucks, Allergan, Amazon: Doug Kass' Views

  • By Doug Kass
  • Jan 2, 2017 1:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.